# Eton Pharmaceuticals, Inc.: Form 8-K, filed Dec 12, 2024

- Company: [Eton Pharmaceuticals, Inc.](/companies/eton.md) (CIK 1710340)
- Form: 8-K
- Filed: 2024-12-12
- Accepted by EDGAR: Dec 12, 2024, 16:30 ET
- Period: 2024-12-10
- Accession: 0001437749-24-037367
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1710340/000143774924037367/eton20241211_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1710340/000143774924037367/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1710340/000143774924037367/eton20241211_8k.htm

Filed Dec 12, 2024.
Source: SEC EDGAR, the filing index for accession 0001437749-24-037367. Last ingested by Listed: Nov 2, 2026, 07:01 ET. No prices; not investment advice.